vs
ICU MEDICAL INC（ICUI）与IES Holdings, Inc.（IESC）财务数据对比。点击上方公司名可切换其他公司
IES Holdings, Inc.的季度营收约是ICU MEDICAL INC的1.6倍（$871.0M vs $540.7M），IES Holdings, Inc.净利率更高（10.5% vs -2.9%，领先13.4%），IES Holdings, Inc.同比增速更快（16.2% vs -14.1%），ICU MEDICAL INC自由现金流更多（$36.0M vs $-18.9M），过去两年IES Holdings, Inc.的营收复合增速更高（11.1% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
IES Holdings, Inc.前身为Integrated Electrical Services, Inc.，主营业务为集成电气及技术系统的设计与安装，同时面向数据中心、住宅、商业和工业设施等多元终端市场提供基础设施类产品及相关服务。
ICUI vs IESC — 直观对比
营收规模更大
IESC
是对方的1.6倍
$540.7M
营收增速更快
IESC
高出30.3%
-14.1%
净利率更高
IESC
高出13.4%
-2.9%
自由现金流更多
ICUI
多$54.8M
$-18.9M
两年增速更快
IESC
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $871.0M |
| 净利润 | $-15.7M | $91.8M |
| 毛利率 | 37.5% | 25.3% |
| 营业利润率 | 1.0% | 11.2% |
| 净利率 | -2.9% | 10.5% |
| 营收同比 | -14.1% | 16.2% |
| 净利润同比 | 34.0% | 59.1% |
| 每股收益（稀释后） | $-0.63 | $4.51 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUIIESC
| Q4 25 | $540.7M | $871.0M | ||
| Q3 25 | $537.0M | $897.8M | ||
| Q2 25 | $548.9M | $890.2M | ||
| Q1 25 | $604.7M | $834.0M | ||
| Q4 24 | $629.8M | $749.5M | ||
| Q3 24 | $589.1M | $775.8M | ||
| Q2 24 | $596.5M | $768.4M | ||
| Q1 24 | $566.7M | $705.7M |
净利润ICUIIESC
| Q4 25 | $-15.7M | $91.8M | ||
| Q3 25 | $-3.4M | $102.3M | ||
| Q2 25 | $35.3M | $79.3M | ||
| Q1 25 | $-15.5M | $72.6M | ||
| Q4 24 | $-23.8M | $57.7M | ||
| Q3 24 | $-33.0M | $65.5M | ||
| Q2 24 | $-21.4M | $66.6M | ||
| Q1 24 | $-39.5M | $56.8M |
毛利率ICUIIESC
| Q4 25 | 37.5% | 25.3% | ||
| Q3 25 | 37.4% | 26.0% | ||
| Q2 25 | 37.9% | 26.9% | ||
| Q1 25 | 34.7% | 25.0% | ||
| Q4 24 | 36.1% | 23.8% | ||
| Q3 24 | 34.8% | 24.0% | ||
| Q2 24 | 34.8% | 25.3% | ||
| Q1 24 | 32.7% | 24.3% |
营业利润率ICUIIESC
| Q4 25 | 1.0% | 11.2% | ||
| Q3 25 | 2.6% | 11.6% | ||
| Q2 25 | 1.9% | 12.6% | ||
| Q1 25 | 2.1% | 11.1% | ||
| Q4 24 | 6.0% | 10.0% | ||
| Q3 24 | 1.4% | 9.7% | ||
| Q2 24 | 1.3% | 11.7% | ||
| Q1 24 | -1.9% | 11.0% |
净利率ICUIIESC
| Q4 25 | -2.9% | 10.5% | ||
| Q3 25 | -0.6% | 11.4% | ||
| Q2 25 | 6.4% | 8.9% | ||
| Q1 25 | -2.6% | 8.7% | ||
| Q4 24 | -3.8% | 7.7% | ||
| Q3 24 | -5.6% | 8.4% | ||
| Q2 24 | -3.6% | 8.7% | ||
| Q1 24 | -7.0% | 8.0% |
每股收益（稀释后）ICUIIESC
| Q4 25 | $-0.63 | $4.51 | ||
| Q3 25 | $-0.14 | $4.99 | ||
| Q2 25 | $1.43 | $3.81 | ||
| Q1 25 | $-0.63 | $3.50 | ||
| Q4 24 | $-0.97 | $2.72 | ||
| Q3 24 | $-1.35 | $3.06 | ||
| Q2 24 | $-0.88 | $2.67 | ||
| Q1 24 | $-1.63 | $2.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $258.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $961.1M |
| 总资产 | $4.1B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ICUIIESC
| Q4 25 | — | $258.7M | ||
| Q3 25 | — | $231.8M | ||
| Q2 25 | — | $168.3M | ||
| Q1 25 | — | $88.3M | ||
| Q4 24 | $308.6M | $112.0M | ||
| Q3 24 | $312.5M | $135.8M | ||
| Q2 24 | $302.6M | $44.9M | ||
| Q1 24 | $251.4M | $106.0M |
股东权益ICUIIESC
| Q4 25 | $2.1B | $961.1M | ||
| Q3 25 | $2.1B | $884.0M | ||
| Q2 25 | $2.1B | $781.4M | ||
| Q1 25 | $2.0B | $705.8M | ||
| Q4 24 | $2.0B | $652.4M | ||
| Q3 24 | $2.0B | $611.1M | ||
| Q2 24 | $2.0B | $567.5M | ||
| Q1 24 | $2.1B | $534.8M |
总资产ICUIIESC
| Q4 25 | $4.1B | $1.7B | ||
| Q3 25 | $4.1B | $1.6B | ||
| Q2 25 | $4.1B | $1.5B | ||
| Q1 25 | $4.2B | $1.4B | ||
| Q4 24 | $4.2B | $1.3B | ||
| Q3 24 | $4.3B | $1.2B | ||
| Q2 24 | $4.3B | $1.2B | ||
| Q1 24 | $4.3B | $1.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $-18.9M |
| 自由现金流率自由现金流/营收 | 6.6% | -2.2% |
| 资本支出强度资本支出/营收 | 4.6% | 5.3% |
| 现金转化率经营现金流/净利润 | — | 0.30× |
| 过去12个月自由现金流最近4个季度 | $91.8M | $175.9M |
8季度趋势，按日历期对齐
经营现金流ICUIIESC
| Q4 25 | $60.6M | $27.7M | ||
| Q3 25 | $56.7M | $132.0M | ||
| Q2 25 | $11.2M | $92.0M | ||
| Q1 25 | $51.3M | $24.8M | ||
| Q4 24 | $40.2M | $37.3M | ||
| Q3 24 | $36.1M | $92.8M | ||
| Q2 24 | $82.0M | $82.9M | ||
| Q1 24 | $45.8M | $33.7M |
自由现金流ICUIIESC
| Q4 25 | $36.0M | $-18.9M | ||
| Q3 25 | $27.6M | $112.0M | ||
| Q2 25 | $-8.5M | $74.8M | ||
| Q1 25 | $36.7M | $7.9M | ||
| Q4 24 | $16.1M | $24.1M | ||
| Q3 24 | $16.2M | $78.5M | ||
| Q2 24 | $62.5M | $65.4M | ||
| Q1 24 | $29.9M | $26.9M |
自由现金流率ICUIIESC
| Q4 25 | 6.6% | -2.2% | ||
| Q3 25 | 5.1% | 12.5% | ||
| Q2 25 | -1.5% | 8.4% | ||
| Q1 25 | 6.1% | 0.9% | ||
| Q4 24 | 2.6% | 3.2% | ||
| Q3 24 | 2.7% | 10.1% | ||
| Q2 24 | 10.5% | 8.5% | ||
| Q1 24 | 5.3% | 3.8% |
资本支出强度ICUIIESC
| Q4 25 | 4.6% | 5.3% | ||
| Q3 25 | 5.4% | 2.2% | ||
| Q2 25 | 3.6% | 1.9% | ||
| Q1 25 | 2.4% | 2.0% | ||
| Q4 24 | 3.8% | 1.8% | ||
| Q3 24 | 3.4% | 1.8% | ||
| Q2 24 | 3.3% | 2.3% | ||
| Q1 24 | 2.8% | 1.0% |
现金转化率ICUIIESC
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 1.29× | ||
| Q2 25 | 0.32× | 1.16× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 1.42× | ||
| Q2 24 | — | 1.24× | ||
| Q1 24 | — | 0.59× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
IESC
| Communications | $351.9M | 40% |
| Single Family Electrical Contracts | $137.0M | 16% |
| Custom Engineered Solutions | $116.0M | 13% |
| Commercialand Industrial | $94.8M | 11% |
| Single Family Contracts Plumbing HVAC | $82.9M | 10% |
| Multi Familyand Other | $64.2M | 7% |
| Industrial Services | $24.2M | 3% |
